Search results for "Adjuvant"

showing 10 items of 733 documents

A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or…

2005

Hepatitis B virus (HBV) core particles carrying the amino-terminal 120 amino acids (aa) of the nucleocapsid (N) protein of the hantaviruses Dobrava, Hantaan or Puumala have been demonstrated to be highly immunogenic in mice when complexed with adjuvants. Here we demonstrate that even without adjuvant, these chimeric particles induced high-titered, and strongly cross-reactive N-specific antibody responses in BALB/c and C57BL/6 mice. The induced N-specific antibodies represented all IgG subclasses. Pre-existing core-specific antibodies did not abrogate the induction of an N-specific immune response by a hantavirus N insert presented on core particles. Therefore, chimeric core particles should…

Orthohantavirusmedicine.medical_treatmentEnzyme-Linked Immunosorbent AssaySaccharomyces cerevisiaeCross Reactionsmedicine.disease_causeAntibodies ViralVirusMiceOrthohepadnavirusAdjuvants ImmunologicmedicineEscherichia coliAnimalsImmunization ScheduleHantavirusHepatitis B virusMice Inbred BALB CVaccines SyntheticGeneral VeterinaryGeneral Immunology and MicrobiologybiologyImmunogenicityPublic Health Environmental and Occupational Healthvirus diseasesNucleocapsid Proteinsbiology.organism_classificationVirologyHepatitis B Core AntigensMice Inbred C57BLInfectious DiseasesHepadnaviridaeImmunoglobulin Gbiology.proteinMolecular MedicineFemaleAntibodyCarrier ProteinsAdjuvantPlasmidsVaccine
researchProduct

The Wnt/beta-Catenin Pathway Attenuates Experimental Allergic Airway Disease

2014

Abstract Signaling via the Wnt/β-catenin pathway plays crucial roles in embryogenesis and homeostasis of adult tissues. In the lung, the canonical Wnt/β-catenin pathway has been implicated in remodeling processes, development of emphysema, and fibrosis. However, its relevance for the modulation of allergic responses in the lung remains unclear. Using genetically modified mice with lung-specific inducible (doxycycline) Wnt-1 expression (CCSP-rtTA × tetO-Wnt1), the impact of Wnt on the development of allergic airway disease was analyzed. Overexpression of Wnt during the allergen challenge phase attenuated the development of airway inflammation in an acute model, as well as in a more therapeut…

OvalbuminTransgeneT cellT-LymphocytesImmunologyMice TransgenicWnt1 ProteinMiceAdjuvants ImmunologicFibrosisCell MovementmedicineRespiratory HypersensitivityImmunology and AllergyAnimalsLungCells Culturedbeta CateninMice Inbred BALB CLungbusiness.industryWnt signaling pathwayDendritic Cellsrespiratory systemmedicine.diseaseFlow CytometryIn vitroCoculture Techniquesrespiratory tract diseasesMice Inbred C57BLmedicine.anatomical_structureCateninDoxycyclineImmunologyCytokinesbusinessLithium ChlorideHomeostasisSignal Transduction
researchProduct

Neoadjuvant chemotherapy in advanced-stage ovarian cancer – state of the art

2022

: Ovarian cancer represents the fifth cause of cancer death among women, carrying one of the worst prognoses among gynaecological malignancies. The need to achieve no residual disease after surgery in order to optimize prognosis of advanced-stage ovarian cancer introduced the idea of neoadjuvant chemotherapy. The present review aims to summarize current state-of-the-art evidence regarding the efficacy and safety of neoadjuvant chemotherapy as well as novel insights regarding the usage of modern therapeutic regimens in the context of neoadjuvant chemotherapy. The last decade has been characterized by the breakthrough scientific evidence that neoadjuvant chemotherapy followed by interval debu…

PARP inhibitorOvarian cancerEndocrinology Diabetes and MetabolismObstetrics and Gynecologystate of the artDiagnostic laparoscopyNeoadjuvant chemotherapySettore MED/40 - Ginecologia E OstetriciaMenopausal Review
researchProduct

PD-1/PD-L1 Checkpoints and Resveratrol: A Controversial New Way for a Therapeutic Strategy

2021

Simple Summary Over the last decade, immunotherapies using antibodies targeting the programmed cell death 1 (PD-1) checkpoint or its ligand, programmed death ligand 1 (PD-L1), have emerged as promising therapeutic strategies against cancer. However, some current limitations include a relatively low rate of “responders”, the high cost of the treatment, and a rare risk of hyper-progression. Currently, the main challenge is, therefore, to improve these therapies, for instance, by using combined approaches. Here, we summarize the accumulating evidence that resveratrol (RSV) plays a role in the modulation of the PD-1/PD-L1 axis in cancer cells, suggesting the potential of therapeutic strategies …

PD-L1Cancer Researchmedicine.medical_treatmentContext (language use)ReviewResveratrolresveratrolchemistry.chemical_compoundImmune systemPD-L1PD-1medicinepolyphenolsRC254-282biologybusiness.industryCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensImmunotherapymedicine.diseaseOncologychemistryCancer cellbiology.proteinCancer researchimmunotherapybusinessAdjuvantCancers
researchProduct

Langerhans's cell histiocytosis in old subjects: two rare case reports and review of the literature

2012

Background: Langerhans cell histiocytosis (LCH) is a proliferative disease of histiocyte-like cells that generally affects children; LCH onset is rare in adults; immunohistochemistry is essential to obtain the correct diagnosis, and treatment protocols are controversial. Objective: To describe two new cases of adult onset oral LCH. Case reports: Case 1: a 71-year-old woman, complaining of diffuse oral pain, presented with erythematous mucosal lesions; the panoramic radiograph and CT scan showed multiple mandible radiolucent areas. Immunohistochemical assay for S-100, CD1a and langerin test was essential in reaching the correct diagnosis. Case 2: a 77-year-old female patient presented with a…

PalateLangerhans's cell histiocytosisS100 ProteinsAntineoplastic AgentsAntineoplastic Agents Phytogeniclangerhans’s cell histiocytosis old subjects langerin oral immunohistochemistryAntigens CD1Diagnosis DifferentialSettore MED/28 - MALATTIE ODONTOSTOMATOLOGICHEHistiocytosis Langerhans-CellMannose-Binding LectinsAntigens CDErythemaCladribineHumansFemaleLectins C-TypeMandibular DiseasesRadiotherapy AdjuvantVulvar DiseasesMouth DiseasesPeriodontal DiseasesAgedEtoposide
researchProduct

Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness.

2001

Some pain syndromes may be difficult to treat due to a poor response to opioids. This situation demands a range of alternative measures, including the use of adjuvant drugs with independent effects, such as antidepressants, sodium channel-blocking agents, steroids and anti-inflammatory drugs (NSAIDs); drugs that reduce opioid side effects; and drugs that enhance analgesia produced by opioids, such as N-methyl-D-aspartate (NMDA) antagonists, calcium channel antagonists, and clonidine. Other approaches, including opioid trials, neural blockade when necessary, and psychological interventions, also may be useful.

Palliative carebusiness.industrymedicine.medical_treatmentCalcium channelAnalgesicPalliative CareDrug ResistanceDrug SynergismBioinformaticsClonidineAnalgesics OpioidAnesthesiology and Pain MedicineOpioidAnesthesiaNeoplasmsNeuropathic painMedicineHumansNeurology (clinical)businessCancer painAdjuvantGeneral Nursingmedicine.drugJournal of pain and symptom management
researchProduct

Gastric cancer: epidemiology, pathology and treatment.

2003

Gastric cancer incidence and mortality has fallen dramatically over the last 50 years in many regions, but remains the second most common cancer worldwide. Despite a marked decline in fundic and distal tumors, there is a rising incidence of adenocarcinomas of the gastroesophageal junction and gastric cardia, particularly in Western nations. This may imply that there are in fact two diseases differing from each other in epidemiology, etiology, pathology and clinical expression. While surgical resection remains the cornerstone of gastric cancer treatment, the optimum extent of nodal resection remains controversial, with randomized studies failing to show that the D2 procedure improves surviva…

Pathologymedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentCancerHematologyGastroesophageal Junction Adenocarcinomamedicine.diseaseChemotherapy regimenRadiation therapyOncologyChemotherapy AdjuvantRisk FactorsStomach NeoplasmsEpidemiology of cancerMedicineHumansRadiotherapy AdjuvantbusinessAdjuvantEpirubicinmedicine.drugNeoplasm StagingAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Focal topographic changes in inflammatory microcirculation associated with lymphocyte slowing and transmigration

2001

Microcirculation is the primary mechanism for delivering lymphocytes to inflammatory tissues. Blood flow within microvessels ensures a supply of lymphocytes at the blood-endothelial interface. Whether the structure of the inflammatory microcirculation facilitates lymphocyte transmigration is less clear. To illuminate the microcirculatory changes associated with lymphocyte transmigration, we used intravital videomicroscopy to examine the dermal microcirculation after application of the epicutaneous antigen oxazolone. Intravascular injection of fluorescein-labeled dextran demonstrated focal topographic changes in the microcirculation. These focal changes had the appearance of loops or hairpin…

Pathologymedicine.medical_specialtyTime FactorsPhysiologyLymphocyteInflammationBiologyDermatitis ContactMicrocirculationOxazolonechemistry.chemical_compoundImmune systemAdjuvants ImmunologicCell MovementPhysiology (medical)medicineAnimalsLymphocytesSkinSheepMicrocirculationOxazoloneEarBlood flowmedicine.anatomical_structurechemistryImmunologyCirculatory systemsense organsLymphmedicine.symptomCardiology and Cardiovascular MedicineAmerican Journal of Physiology-Heart and Circulatory Physiology
researchProduct

Adjuvant Effect of Titanium Brushes in Peri-Implant Surgical Treatment: A Systematic Review

2021

Background: the prognosis of peri-implant surgery can be affected by poor decontamination of the implant surface, which could be improved with the use of titanium brushes. The objectives of this systematic review were to evaluate the effectiveness of titanium brushes in the decontamination of the implant surface in terms of plaque index, probing depth, bleeding on probing and bone loss/gain; as well as its effectiveness according to the type of peri-implant bone defect. Methods: an electronic search was carried out in the PubMed, Scopus, Cochrane and Embase databases, as well as a manual search. The search strategy included four keywords: “Peri-implantitis”, “Periimplantitis”, “Implant Surf…

Peri-implantitisImplant surfacemedicine.medical_treatmentBleeding on probingperi-implant surgerychemistry.chemical_elementDentistry03 medical and health sciences0302 clinical medicinemedicine030212 general & internal medicineSurgical treatmentGeneral Dentistryimplant surfacebusiness.industrytitanium brushRK1-715030206 dentistrydecontaminationSystematic reviewchemistryDentistryImplantSystematic Reviewmedicine.symptombusinessAdjuvantTitaniumperi-implantitisDentistry Journal
researchProduct

Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials.

2019

According to WHO (World Health Organization) reports, more than 770,000 people died from HIV and almost 1.7 million people becoming newly infected in the worldwide in 2018. Therefore, many attempts should be done to produce a forceful vaccine to control the AIDS. DNA-based vaccines have been investigated for HIV vaccination by researches during the recent 20 years. The DNA vaccines are novel approach for induction of both type of immune responses (cellular and humoral) in the host cells and have many advantages including high stability, fast and easy of fabrication and absence of severe side effects when compared with other vaccination methods. Recent studies have been focused on vaccine de…

Pharmaceutical ScienceHIV Infections02 engineering and technologyVirusDNA vaccination03 medical and health sciencesImmune systemAcquired immunodeficiency syndrome (AIDS)AntigenAdjuvants ImmunologicmedicineVaccines DNAAnimalsHumansVector (molecular biology)030304 developmental biologyAIDS Vaccines0303 health sciencesClinical Trials as TopicImmunity Cellularbusiness.industryVaccination021001 nanoscience & nanotechnologymedicine.diseaseImmunity HumoralVaccinationClinical trialImmunology0210 nano-technologybusinessJournal of controlled release : official journal of the Controlled Release Society
researchProduct